Viewing Study NCT06216093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-06-14 @ 1:32 PM
Study NCT ID: NCT06216093
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-15
First Post: 2024-01-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years
Sponsor: EuBiologics Co.,Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Syncytial Virus Infections View
None Respiratory Syncytial Virus (RSV) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EuRSV View
None RSV View
None Respiratory Syncytial Virus View